|
|
||||||||
From the Departments of Neurology (L.E.J., I.M.N., P.W.-W., H.H.M., D.S.D., D.N., N.F.-S., H.O.L.), Neurosurgery (W.E.B.), Biostatistics (F.K., R.O.), and Pathology (R.A.P.), Cleveland Clinic Foundation, Cleveland, OH; Department of Neurosurgery, American University of Beirut, Lebanon (Y.C.); Department of Neurology, Hospital de Niños Santísima Trinidad, Córdoba, Argentina (J.B.); and Park Ridge Hospital (A.G.), Asheville, NC.
Address correspondence and reprint requests to Dr. Lara E. Jeha, Department of Neurology, S51, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: jehil{at}ccf.org
To assess short- and long-term seizure freedom, the authors reviewed 371 patients who underwent anterior temporal lobectomy to treat pharmacoresistant epilepsy. The mean follow-up duration was 5.5 years (range 1 to 14.1 years). Fifty-three percent of patients were seizure free at 10 years. The authors identified multiple predictors of recurrence. Results of EEG performed 6 months postoperatively correlated with occurrence and severity of seizure recurrence, in addition to breakthrough seizures with discontinuation of antiepileptic drugs.
Disclosure: The authors report no conflicts of interest.
Received May 19, 2005. Accepted in final form March 2, 2006.
This article has been cited by other articles:
![]() |
H. Choi, R. L. Sell, L. Lenert, P. Muennig, R. R. Goodman, F. G. Gilliam, and J. B. Wong Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy: A Decision Analysis JAMA, December 3, 2008; 300(21): 2497 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Jeha, I. Najm, W. Bingaman, D. Dinner, P. Widdess-Walsh, and H. Luders Surgical outcome and prognostic factors of frontal lobe epilepsy surgery Brain, February 1, 2007; 130(2): 574 - 584. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |